Denali Therapeutics
DNLI
DNLI
108 hedge funds and large institutions have $1.23B invested in Denali Therapeutics in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 118 → 108 (-10)
21% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 38
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Holders
108
Holding in Top 10
3
Calls
$1.24M
Puts
$920K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$6.93M | |
| 3 | +$3.95M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.92M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$13.8M | |
| 3 | -$1.56M | |
| 4 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
-$1.21M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$1.1M |